Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950136-06-001028
Filing Date
2006-02-14
Accepted
2006-02-14 16:49:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G file001.htm SC 13G 8783
  Complete submission text file 0000950136-06-001028.txt   10684
Mailing Address 155 FEDERAL STREET BOSTON MA 02110
Business Address 155 FEDERAL STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Subject) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48323 | Film No.: 06616390
SIC: 2834 Pharmaceutical Preparations

Mailing Address NARRAGANSETT MANAGEMENT, LP 540 MADISON AVENUE, 38TH FLOOR NEW YORK NY 10022
Business Address 212.813.5855
Dowling Joseph L III (Filed by) CIK: 0001297011 (see all company filings)

Type: SC 13G